Bayer announced that the U.S. Food and Drug Administration approved AMBELVIST (gadoquatrane), a macrocyclic gadolinium-based contrast agent for magnetic resonance ...

(Premium-only article. Please sign in or upgrade to SI Premium to view.)

FDA